Innospec Inc. (NASDAQ:IOSP) insider Philip Curran sold 375 shares of the company’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $71.56, for a total transaction of $26,835.00. Following the completion of the sale, the insider now directly owns 2,968 shares in the company, valued at $212,390.08. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Philip Curran also recently made the following trade(s):

  • On Friday, November 24th, Philip Curran sold 1,352 shares of Innospec stock. The shares were sold at an average price of $71.05, for a total transaction of $96,059.60.

Innospec Inc. (NASDAQ IOSP) traded down $1.15 during trading on Friday, reaching $68.90. 72,917 shares of the company’s stock traded hands, compared to its average volume of 95,452. The company has a market cap of $1,660.00, a PE ratio of 16.48 and a beta of 1.20. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.35 and a current ratio of 2.24. Innospec Inc. has a 52-week low of $54.10 and a 52-week high of $74.75.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, November 7th. The specialty chemicals company reported $1.00 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.85 by $0.15. The firm had revenue of $332.40 million for the quarter, compared to analysts’ expectations of $309.40 million. Innospec had a net margin of 7.45% and a return on equity of 15.05%. The business’s revenue was up 61.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.78 EPS. equities analysts forecast that Innospec Inc. will post 4.3 EPS for the current year.

The business also recently declared a semiannual dividend, which was paid on Monday, November 27th. Shareholders of record on Thursday, November 16th were issued a $0.39 dividend. This is a boost from Innospec’s previous semiannual dividend of $0.38. This represents a yield of 1.12%. The ex-dividend date was Wednesday, November 15th. Innospec’s dividend payout ratio is currently 21.55%.

A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. raised its holdings in Innospec by 2.4% in the 2nd quarter. BlackRock Inc. now owns 3,041,897 shares of the specialty chemicals company’s stock valued at $199,396,000 after acquiring an additional 70,615 shares during the period. FMR LLC grew its position in shares of Innospec by 0.6% during the 2nd quarter. FMR LLC now owns 2,612,586 shares of the specialty chemicals company’s stock worth $171,256,000 after purchasing an additional 16,353 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Innospec by 3.9% during the 2nd quarter. Vanguard Group Inc. now owns 2,185,201 shares of the specialty chemicals company’s stock worth $143,239,000 after purchasing an additional 82,013 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Innospec by 0.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,359,181 shares of the specialty chemicals company’s stock worth $83,793,000 after purchasing an additional 11,097 shares in the last quarter. Finally, Wells Fargo & Company MN grew its position in shares of Innospec by 12.4% during the 3rd quarter. Wells Fargo & Company MN now owns 1,063,714 shares of the specialty chemicals company’s stock worth $65,578,000 after purchasing an additional 117,395 shares in the last quarter. 91.20% of the stock is currently owned by hedge funds and other institutional investors.

IOSP has been the topic of a number of research analyst reports. Zacks Investment Research cut shares of Innospec from a “buy” rating to a “hold” rating in a report on Wednesday, October 18th. Monness Crespi & Hardt raised shares of Innospec from a “neutral” rating to a “buy” rating and set a $65.00 price target on the stock in a report on Tuesday, August 22nd. KeyCorp reissued an “overweight” rating on shares of Innospec in a report on Thursday, November 9th. ValuEngine raised shares of Innospec from a “hold” rating to a “buy” rating in a report on Thursday, November 9th. Finally, Johnson Rice raised shares of Innospec from a “hold” rating to an “accumulate” rating in a report on Tuesday, November 14th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $70.50.

TRADEMARK VIOLATION WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/09/philip-curran-sells-375-shares-of-innospec-inc-iosp-stock.html.

Innospec Company Profile

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Stock Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related stocks with our FREE daily email newsletter.